NF-κB-HOTAIR axis links DNA damage response, chemoresistance and cellular senescence in ovarian cancer

Oncogene

Volumn 35, Issue 41, 2016, Pages 5350-5361

  Ozes A R ^a   Miller, D F ^b   Ozes O N ^c   Fang, F ^b   Liu, Y ^d,e,f   Matei, D ^d,f   Huang, T ^g   Nephew, K P ^a,b,d,f  

^a INDIANA UNIVERSITY   (United States)

^b Indiana University School of Medicine   (United States)

^c AKDENIZ UNIVERSITY   (Turkey)

^d INDIANA UNIVERSITY   (United States)

^e INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY RNA; HOX TRANSCRIPT ANTISENSE RNA; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; PLATINUM DERIVATIVE; UNCLASSIFIED DRUG; CARRIER PROTEIN; HOTAIR LONG UNTRANSLATED RNA, HUMAN; IKBKAP PROTEIN, HUMAN; LONG UNTRANSLATED RNA; PLATINUM;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CANCER RECURRENCE; CANCER RESISTANCE; CONTROLLED STUDY; DNA DAMAGE RESPONSE; DOUBLE STRANDED DNA BREAK; ECTOPIC EXPRESSION; FEMALE; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; OVARY CANCER; POSITIVE FEEDBACK; PRIMARY TUMOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SENESCENCE; SINGLE BLIND PROCEDURE; UPREGULATION; BIOSYNTHESIS; CELL AGING; DNA DAMAGE; DRUG EFFECTS; DRUG RESISTANCE; GENE EXPRESSION REGULATION; GENETICS; OVARIAN NEOPLASMS; PATHOLOGY; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

CARRIER PROTEINS; CELL AGING; CELL LINE, TUMOR; DNA BREAKS, DOUBLE-STRANDED; DNA DAMAGE; DRUG RESISTANCE, NEOPLASM; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; NF-KAPPA B; OVARIAN NEOPLASMS; PLATINUM; RNA, LONG NONCODING; SIGNAL TRANSDUCTION;

EID: 84962070971     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2016.75     Document Type: Article

References (57)

1. Zhang X-P, Liu F, Wang W. Regulation of the DNA damage response by p53 cofactors. Biophys J 2012; 102: 2251-2260.
2. Chien Y, Scuoppo C, Wang X, Fang X, Balgley B, Bolden JE et al. Control of the senescence-associated secretory phenotype by NF-B promotes senescence and enhances chemosensitivity. Genes Dev 2011; 25: 2125-2136.
3. Wang J, Jacob NK, Ladner KJ, Beg A, Perko JD, Tanner SM et al. RelA/p65 functions to maintain cellular senescence by regulating genomic stability and DNA repair. EMBO Rep 2009; 10: 1272-1278.
4. Wu Z-H, Shi Y, Tibbetts RS, Miyamoto S. Molecular linkage between the kinase ATM and NF-B signaling in response to genotoxic stimuli. Science 2006; 311: 1141-1146.
5. Janssens S, Tinel A, Lippens S, Tschopp J. PIDD mediates NF-B activation in response to DNA damage. Cell 2005; 123: 1079-1092.
6. Deans AJ, West SC. DNA interstrand crosslink repair and cancer. Nat Rev Cancer 2011; 11: 467-480.
7. Guttman M, Amit I, Garber M, French C, Lin MF, Feldser D et al. Chromatin signature reveals over a thousand highly conserved large non-coding RNAs in mammals. Nature 2009; 458: 223-227.
8. Wan G, Hu X, Liu Y, Han C, Sood AK, Calin GA et al. A novel noncoding RNA lncRNAJADE connects DNA damage signalling to histone H4 acetylation. EMBO J 2013; 32: p 2833-2847.
9. Huarte M, Guttman M, Feldser D, Garber M, Koziol MJ, Kenzelmann-Broz D et al. A large intergenic noncoding RNA induced by p53 mediates global gene repression in the p53 response. Cell 2010; 142: p 409-419.
10. Hung T, Wang Y, Lin MF, Koegel AK, Kotake Y, Grant GD et al. Extensive and coordinated transcription of noncoding RNAs within cell-cycle promoters. Nat Genet 2011; 43: 621-629.
11. Tsai M-C, Spitale RC, Chang HY. Long intergenic noncoding RNAs: new links in cancer progression. Cancer Res 2011; 71: p 3-7.
12. Gupta RA, Shah N, Wang KC, Kim J, Horlings HM, Wong DJ et al. Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Nature 2010; 464: 1071-1076.
13. Guil S, Soler M, Portela A, Carrère J, Fonalleras E, Gómez et al. Intronic RNAs mediate EZH2 regulation of epigenetic targets. Nat Struct Mol Biol 2012; 19: 664-670.
14. Chu C, Qu K, Zhong FL, Artandi SE, Chang HY. Genomic maps of long noncoding RNA occupancy reveal principles of RNA-chromatin interactions. Mol Cell 2011; 44: 667-678.
15. Balch C, Huang TH, Brown R, Nephew KP. The epigenetics of ovarian cancer drug resistance and resensitization. Am J Obst Gynecol 2004; 191: 1552-1572.
16. Liu L, Guo J, Yu L, Cai J, Gui T, Tang H et al. miR-101 regulates expression of EZH2 and contributes to progression of and cisplatin resistance in epithelial ovarian cancer. Tumor Biol 2014; 35: 1-8.
17. Hu S, Yu L, Li Z, Shen Y, Wang J, Cai J et al. Overexpression of EZH2 contributes to acquired cisplatin resistance in ovarian cancer cells in vitro and in vivo. Cancer Biol Ther 2010; 10: 788-795.
18. Lee ST, Li Z, Wu Z, Aau M, Guan P, Karuturi RK et al. Context-specific regulation of NF-B target gene expression by EZH2 in breast cancers. Mol Cell 2011; 43: 798-810.
19. Yang G, Xiao X, Rosen DG, Cheng X, Wu X, Chang B et al. The biphasic role of NF-B in progression and chemoresistance of ovarian cancer. Clin Cancer Res 2011; 17: 2181-2194.
20. Network, C.G.A.R., Integrated genomic analyses of ovarian carcinoma. Nature 2011; 474: 609-615.
21. Ciccia A, Elledge SJ. The DNA damage response: making it safe to play with knives. Mol Cell 2010; 40: 179-204.
22. Zandi E, Rothwarf DM, Delhase M, Hayakawa M, Karin M. The IB kinase complex (IKK) contains two kinase subunits, IKK and IKK, necessary for IB phosphorylation and NF-B activation. Cell 1997; 91: 243-252.
23. Ozes ON, Mayo LD, Gustin JA, Pfeffer SR, Pfeffer LM, Donner DB. NF-B activation by tumour necrosis factor requires the Akt serine-threonine kinase. Nature 1999; 401: 82-85.
24. Canino C, Mori F, Cambria A, Diamantini A, Germoni S, Alessandrini G et al. SASP mediates chemoresistance and tumor-initiating-activity of mesothelioma cells. Oncogene 2011; 31: 3148-3163.
25. Rodier F, Coppé JP, Patil CK, Hoeijmakers WA, Munõz DP, Raza SR, Freund et al. Persistent DNA damage signalling triggers senescence-associated inflammatory cytokine secretion. Nat Cell Biol 2009; 11: 973-979.
26. Gilbert LA, Hemann MT. DNA damage-mediated induction of a chemoresistant niche. Cell 2010; 143: 355-366.
27. Kuilman T, Michaloglou C, Vredeveld LC, Douma S, van Doorn R, Desmet CJ et al. Oncogene-induced senescence relayed by an interleukin-dependent inflammatory network. Cell 2008; 133: 1019-1031.
28. Bieging KT, Mello SS, Attardi LD. Unravelling mechanisms of p53-mediated tumour suppression. Nat Rev Cancer 2014; 14: 359-370.
29. Liu Z, Sun M, Lu K, Liu J, Zhang M, Wu W, De W et al. The long noncoding RNA HOTAIR contributes to cisplatin resistance of human lung adenocarcinoma cells via downregualtion of p21 (WAF1/CIP1) expression. PLoS One 2013; 8: e77293.
30. Jing L, Yuan W, Ruofan D, Jinjin Y, Haifeng Q. HOTAIR enhanced aggressive biological behaviors and induced radio-resistance via inhibiting p21 in cervical cancer. Tumor Biol 2014; 36: 3611-3619.
31. Debacq-Chainiaux F, Erusalimsky JD, Campisi J, Toussaint O. Protocols to detect senescence-associated beta-galactosidase (SA-gal) activity, a biomarker of senescent cells in culture and in vivo. Nat Protoc 2009; 4: 1798-1806.
32. Malek E, Jagannathan S, Driscoll JJ. Correlation of long non-coding RNA expression with metastasis, drug resistance and clinical outcome in cancer. Oncotarget 2014; 5: 8027.
33. Wu Z-H, Wang XL, Tang HM, Jiang T, Chen J, Lu S et al. Long non-coding RNA HOTAIR is a powerful predictor of metastasis and poor prognosis and is associated with epithelial-mesenchymal transition in colon cancer. Oncol Rep 2014; 32: 395-402.
34. Qiu J, Lin YY, Ye LC, Ding JX, Feng WW, Jin HY. Overexpression of long non-coding RNA HOTAIR predicts poor patient prognosis and promotes tumor metastasis in epithelial ovarian cancer. Gynecol Oncol 2014; 134: 121-128.
35. Vaughan S, Coward JI, Bast Jr RC, Berchuck A, Berek JS, Brenton JD et al. Rethinking ovarian cancer: recommendations for improving outcomes. Nat Rev Cancer 2011; 11: 719-725.
36. de Visser KE, Eichten A, Coussens LM. Paradoxical roles of the immune system during cancer development. Nat Rev Cancer 2006; 6: 24-37.
37. Kipps E, Tan DS, Kaye SB. Meeting the challenge of ascites in ovarian cancer: new avenues for therapy and research. Nat Rev Cancer 2013; 13: 273-282.
38. Almeida LO, Abrahao AC, Rosselli-Murai LK, Giudice FS, Zagni C, Leopoldino AM et al. NFB mediates cisplatin resistance through histone modifications in head and neck squamous cell carcinoma (HNSCC). FEBS Open Bio 2014; 4: 96-104.
39. Wang Y, Niu XL, Qu Y, Wu J, Zhu YQ, Sun WJ et al. Autocrine production of interleukin-6 confers cisplatin and paclitaxel resistance in ovarian cancer cells. Cancer Lett 2010; 295: 110-123.
40. Dijkgraaf EM, Heusinkveld M, Tummers B, Vogelpoel LT, Goedemans R, Jha V et al. Chemotherapy alters monocyte differentiation to favor generation of cancersupporting M2 macrophages in the tumor microenvironment. Cancer Res 2013; 73: 2480-2492.
41. Kang C, Xu Q, Martin TD, Li MZ, Demaria M, Aron L et al. The DNA damage response induces inflammation and senescence by inhibiting autophagy of GATA4. Science 2015; 349: aaa5612.
42. Laberge R-M, Sun Y, Orjalo AV, Patil CK, Freund A, Zhou L et al. MTOR regulates the pro-tumorigenic senescence-associated secretory phenotype by promoting IL1A translation. Nat Cell Biol 2015; 17: 1049-1061.
43. Heubach J, Monsior J, Deenen R, Niegisch G, Szarvas T, Niedworok C et al. The long noncoding RNA HOTAIR has tissue and cell type-dependent effects on HOX gene expression and phenotype of urothelial cancer cells. Mol Cancer 2015; 14: 108.
44. Sullivan N, Sasser AK, Axel AE, Vesuna F, Raman V, Ramirez N et al. Interleukin-6 induces an epithelial-mesenchymal transition phenotype in human breast cancer cells. Oncogene 2009; 28: 2940-2947.
45. Oliver TG, Mercer KL, Sayles LC, Burke JR, Mendus D, Lovejoy KS et al. Chronic cisplatin treatment promotes enhanced damage repair and tumor progression in a mouse model of lung cancer. Genes Dev 2010; 24: 837-852.
46. Di Micco R, Fumagalli M, Cicalese A, Piccinin S, Gasparini P, Luise C et al. Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication. Nature 2006; 444: 638-642.
47. Yoon J-H, Abdelmohsen K, Kim J, Yang X, Martindale JL, Tominaga-Yamanaka K et al. Scaffold function of long non-coding RNA HOTAIR in protein ubiquitination. Nat Commun 2013, 4: 2939.
48. Di Minin G, Bellazzo A, Dal Ferro M, Chiaruttini G, Nuzzo S, Bicciato S et al. Mutant p53 reprograms TNF signaling in cancer cells through interaction with the tumor suppressor DAB2IP. Mol Cell 2014, 56: 617-629.
49. Cooks T, Pateras IS, Tarcic O, Solomon H, Schetter AJ, Wilder S et al. Mutant p53 prolongs NF-B activation and promotes chronic inflammation and inflammationassociated colorectal cancer. Cancer Cell 2013; 23: 634-646.
50. Li M, Balch C, Montgomery JS, Jeong M, Chung JH, Yan P et al. Integrated analysis of DNA methylation and gene expression reveals specific signaling pathways associated with platinum resistance in ovarian cancer. BMC Med Genet 2009; 2: 34.
51. Matei D, Fang F, Shen C, Schilder J, Arnold A, Zeng Y et al. Epigenetic resensitization to platinum in ovarian cancer. Cancer Res 2012; 72: 2197-2205.
52. Paige JS, Wu KY, Jaffrey SR. RNA mimics of green fluorescent protein. Science 2011; 333: 642-646.
53. Rao X, Di Leva G, Li M, Fang F, Devlin C, Hartman-Frey C et al. MicroRNA-221/222 confers breast cancer fulvestrant resistance by regulating multiple signaling pathways. Oncogene 2010; 30: 1082-1097.
54. Wang Y, Cardenas H, Fang F, Condello S, Taverna P, Segar M et al. Epigenetic targeting of ovarian cancer stem cells. Cancer Res 2014; 74: 4922-4936.
55. Zhang S, Balch C, Chan MW, Lai HC, Matei D, Schilder JM et al. Identification and characterization of ovarian cancer-initiating cells from primary human tumors. Cancer Res 2008; 68: 4311-4320.
56. Miller DF, Yan PS, Buechlein A, Rodriguez BA, Yilmaz AS, Goel S et al. A new method for stranded whole transcriptome RNA-seq. Methods 2013; 63: 126-134.
57. Miller DF, Yan PX, Fang F, Buechlein A, Ford JB, Tang H et al. Stranded whole transcriptome RNASeq for all RNA types. Curr Protoc Hum Genet 2015, 11.14. 1-11.14. 23.